KLEE JUSTIN B. (Co-Chief Executive Officer) sold 0.8% of their position (30.46K shares) of AMYLYX PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $980.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/14/2026ACC: 0001193125-26-390506
DirectorOfficer· Co-Chief Executive Officer
Since Jan 2022
-30.46K
Net shares
Net seller
$980.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
30.46K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−29.02K
Price / share
$32.13
Trade value
$932.55K
% of position
0.8%
9/10/2026
3.64M→3.61M
Common Stock
Direct
Shares
−1.44K
Price / share
$33.16
Trade value
$47.71K
% of position
0.0%
9/10/2026
3.61M→3.61M
Total
Net shares
−30.46K
Net value
-$980.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2026 | S · Sale | −29.02K | $32.13 | $932.55K | 0.8% | 3.64M | 3.61M |
| Common Stock Direct | 9/10/2026 | S · Sale | −1.44K | $33.16 | $47.71K | 0.0% | 3.61M | 3.61M |
| Total | −30.46K | -$980.26K | ||||||
Derivative Transactions0
No derivative transactions reported